Search Results - "Zerbato, Jennifer M."
-
1
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy
Published in PLoS pathogens (01-04-2021)“…HIV persists during antiretroviral therapy (ART) as integrated proviruses in cells descended from a small fraction of the CD4+ T cells infected prior to the…”
Get full text
Journal Article -
2
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
Published in Nature communications (13-07-2021)“…The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously…”
Get full text
Journal Article -
3
Combination Immune Checkpoint Blockade to Reverse HIV Latency
Published in The Journal of immunology (1950) (01-03-2020)“…In people living with HIV on antiretroviral therapy, HIV latency is the major barrier to a cure. HIV persists preferentially in CD4 T cells expressing multiple…”
Get full text
Journal Article -
4
Diverse effects of interferon alpha on the establishment and reversal of HIV latency
Published in PLoS pathogens (28-02-2020)“…HIV latency is the major barrier to a cure for people living with HIV (PLWH) on antiretroviral therapy (ART) because the virus persists in long-lived…”
Get full text
Journal Article -
5
Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection
Published in PLoS pathogens (08-09-2020)“…In HIV-hepatitis B virus (HBV) co-infection, adverse liver outcomes including liver fibrosis occur at higher frequency than in HBV-mono-infection, even…”
Get full text
Journal Article -
6
Clones of infected cells arise early in HIV-infected individuals
Published in JCI insight (20-06-2019)“…In HIV-infected individuals on long-term antiretroviral therapy (ART), more than 40% of the infected cells are in clones. Although most HIV proviruses present…”
Get full text
Journal Article -
7
Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
Published in EBioMedicine (01-03-2021)“…One strategy being pursued to clear latently infected cells that persist in people living with HIV (PLWH) on antiretroviral therapy (ART) is to activate latent…”
Get full text
Journal Article -
8
Enhancement of antibody class-switch recombination by the cumulative activity of four separate elements
Published in The Journal of immunology (1950) (01-11-2011)“…Class-switch recombination of Ab isotype is mediated by a recombinational DNA deletion event and must be robustly upregulated during Ag-driven differentiation…”
Get full text
Journal Article -
9
Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1
Published in Clinical infectious diseases (13-11-2019)“…Abstract Background The latent human immunodeficiency virus type 1 (HIV-1) reservoir represents a major barrier to a cure. Based on the levels of HIV-1 DNA in…”
Get full text
Journal Article -
10
Between a shock and a hard place: challenges and developments in HIV latency reversal
Published in Current opinion in virology (01-10-2019)“…[Display omitted] •HIV latency persists in long-lived and proliferating CD4+ T cells.•Latency is maintained through mechanisms that suppress viral…”
Get full text
Journal Article -
11
Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells
Published in Nature medicine (01-07-2017)“…Sanyal et al . report a new and rapid assay for measuring replication-competent HIV-1 in CD4 + T cells. Although antiretroviral therapy can suppress HIV-1…”
Get full text
Journal Article -
12
Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals
Published in Journal of virology (24-08-2022)“…Co-infection with hepatitis B (HBV) and human immunodeficiency virus (HIV) increases overall and liver-related mortality. In order to identify interactions…”
Get full text
Journal Article -
13
Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4 + T Cells following Latency Reversal
Published in Antimicrobial agents and chemotherapy (01-03-2017)“…Therapeutic strategies that target the latent HIV-1 reservoir in resting CD4 T cells of infected individuals are always administered in the presence of…”
Get full text
Journal Article -
14
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy
Published in AIDS (London) (01-08-2021)“…To quantify HIV specific immunological and virological changes in people living with HIV (PLWH) on antiretroviral therapy (ART) with malignancy who received…”
Get full text
Journal Article -
15
Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro
Published in Journal of virology (15-09-2016)“…The latent HIV-1 reservoir primarily resides in resting CD4(+) T cells which are a heterogeneous population composed of both naive (TN) and memory cells. In…”
Get full text
Journal Article -
16
Persistence of envelopes in different CD4 + T-cell subsets in antiretroviral therapy-suppressed people with HIV
Published in AIDS (London) (01-02-2023)“…Despite suppressive antiretroviral therapy (ART), HIV can persist in a diverse range of CD4+ T-cell subsets. Through longitudinal env sampling from people with…”
Get full text
Journal Article -
17
Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR)
Published in Pathology (01-08-2022)“…During the COVID-19 pandemic, the reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) assay has been the primary method of diagnosis of…”
Get full text
Journal Article -
18
A cure for HIV: how would we know?
Published in The lancet HIV (01-05-2020)Get full text
Journal Article -
19
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal
Published in AIDS (London) (01-01-2022)“…The aim of this study was to examine whether administering both vorinostat and disulfiram to people with HIV (PWH) on antiretroviral therapy (ART) is well…”
Get full text
Journal Article -
20
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
Published in EBioMedicine (01-01-2023)“…HIV can infect multiple cells in the liver including hepatocytes, Kupffer cells and infiltrating T cells, but whether HIV can persist in the liver in people…”
Get full text
Journal Article